A subsidiary of Weigao Group, the company focuses on the R&D, manufacturing, and global marketing of wound repair and wound care products, commanding significant influence in the wound care sector both domestically and internationally. Leveraging the Group’s established global sales network, its products are exported to numerous countries, providing comprehensive chronic wound management solutions to medical institutions worldwide. With the continuing rise in overseas demand for Negative Pressure Wound Therapy (NPWT), there is an urgent need among clients for upstream OEM partners capable of in-house R&D, mass production, and compliant export operations.
The client faced multiple challenges in entering the overseas NPWT market, requiring a partner with comprehensive capabilities to overcome regulatory, technical, and supply chain barriers.
Complex overseas medical device regulations with high entry barriers
Extremely high batch quality consistency requirements for medical consumables
Large overseas orders requiring long-term stable mass production capabilities
Lack of mature self-developed platforms with high costs and long development cycles
Medison provided a comprehensive one-stop NPWT negative pressure wound treatment OEM solution, covering complete R&D support, customized design, mass production, and compliant quality control.
A structured four-phase service process ensuring clarity, quality, and reliable international delivery for OEM cooperation projects.
The project implementation process faced the following challenges, requiring strong professional communication skills and international trade experience from the support team.
Complex multi-country regulatory compliance requirements
High batch quality consistency demands for medical consumables
Large-scale overseas order production scheduling challenges
Strict export logistics and cross-border delivery requirements
The cooperation achieved successful batch supply landing in multiple overseas markets, establishing a long-term stable deep strategic partnership. The project significantly reduced self-development and production costs while shortening overseas product time-to-market cycles.
This collaboration fully demonstrates Medison's capability to provide comprehensive OEM solutions for complex medical device projects, combining technical expertise with production scale and regulatory compliance.
"Medison's complete NPWT negative pressure R&D and mass production system perfectly matches our overseas market layout needs. The mature technology significantly reduces self-development costs, and strict quality control ensures export product stability. Stable supply and continuous technical upgrade support help us rapidly expand our global wound care product line, making them a trustworthy long-term deep-binding OEM strategic partner."
Initiating Long-Term Strategic Cooperation with Medison Device Channels
Medison offers a full range of laser fiber optics and minimally invasive consumables, along with stable supply and supporting clinical technical support. We welcome medical device distributors nationwide to discuss cooperation.